Atrial Fibrillation Trial, Recruiting NCT05617456 Sponsor: Giulio Zucchelli Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT05617456
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been assessed by their doctor as needing an ablation procedure for atrial fibrillation, in line with current medical guidelines.
  • People who are willing and able to give informed consent and attend all required appointments at an approved study centre.
  • People aged 18 or older who are of legal age to give consent under the laws of their state and country.

Who may not be able to join:

  • People who are already enrolled in another research study or registry that would interfere with this trial — exceptions may apply if the other registry is a government-required registry or a purely observational registry with no associated treatments.
  • People who are unwilling or unable to sign the required consent and health information forms.
  • People who are not available or not willing to attend all follow-up visits and examinations for the full duration of the study.
  • People whose doctor estimates their life expectancy to be 12 months or less.
  • People who still have unresolved side effects or complications from a previous invasive procedure.
  • Women who are able to become pregnant and are pregnant, or plan to become pregnant, during the study period (the doctor will determine how this is assessed).
  • People who have been found to have a blood clot in the left chamber of the heart on imaging done within 4 weeks before the ablation procedure.
  • People whose atrial fibrillation is caused by a correctable or non-heart-related condition, such as a thyroid problem, electrolyte imbalance, or another reversible cause.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393283687691

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Giulio Zucchelli
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
1 December 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Baseline patient's characteristic (clinical history and drug therapy) and procedural measures for subjects undergoing catheter ablation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov